Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELP | P16109 | 1/20 | 0.71 |
| ▸ | FABP3 | P05413 | 1/20 | 0.67 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.64 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.64 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.61 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.61 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.61 |
| ▸ | PRKCA | P17252 | 1/20 | 0.61 |
| ▸ | P2RY10 | O00398 | 4/20 | 0.61 |
| ▸ | GPR34 | Q9UPC5 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21641558 | 1.00 | SELP (0.71) | SELPFABP3LPAR3LPAR1ENPP2 | |
| SCHEMBL21641505 | 1.00 | SELP (0.71) | SELPFABP3LPAR3LPAR1ENPP2 | |
| SCHEMBL21641453 | 1.00 | SELP (0.71) | SELPFABP3LPAR3LPAR1ENPP2 | |
| SCHEMBL21581291 | 1.00 | SELP (0.71) | SELPFABP3LPAR3LPAR1ENPP2 | |
| SCHEMBL23256429 | 1.00 | SELP (0.71) | SELPFABP3LPAR3LPAR1ENPP2 | |
| SCHEMBL23188429 | 1.00 | SELP (0.71) | SELPFABP3LPAR3LPAR1ENPP2 | |
| SCHEMBL23256430 | 1.00 | SELP (0.71) | SELPFABP3LPAR3LPAR1ENPP2 | |
| SCHEMBL23209666 | 1.00 | SELP (0.71) | SELPFABP3LPAR3LPAR1ENPP2 | |
| SCHEMBL23387627 | 1.00 | SELP (0.71) | SELPFABP3LPAR3LPAR1ENPP2 | |
| SCHEMBL21641455 | 1.00 | SELP (0.71) | SELPFABP3LPAR3LPAR1ENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116747310-A | Extraction of plant-derived decoction and artificial preparation of herbal and related products thereof | 中国医学科学院基础医学研究所 | 2023-09-15 | — | — | CN | claimed |
| US-20260000768-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS | BEIJING BAISHIHEKANG PHARMACEUTICAL TECH BSJPHARMA CO LTD (CN) | 2026-01-01 | — | — | US | disclosed |
| US-20250345290-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT AND RELATED PRODUCTS THEREOF | BEIJING BAISHIHEKANG PHARMACEUTICAL TECH BSJPHARMA CO LTD (CN) | 2025-11-13 | — | — | US | disclosed |
| US-12280114-B2 | Extraction of plant source “medicinal soup” and manual preparation of “herbal medicine” and related products | INSTITUTE OF BASIC MEDICAL SCIENCES (CN) | 2025-04-22 | — | — | US | disclosed |
| US-20250041423-A1 | EXTRACTION OF PLANT SOURCE \"MEDICINAL SOUP\" AND MANUAL PREPARATION OF \"HERBAL MEDICINE\" AND RELATED PRODUCTS | BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) CO., LTD (CN) | 2025-02-06 | — | — | US | disclosed |
| US-20230305027-A1 | METHODS FOR TREATING EXACERBATIONS OF INFLAMMATORY RESPIRATORY DISEASES | GENENTECH INC (US) | 2023-09-28 | — | — | US | disclosed |
| CN-116747310-A | Extraction of plant-derived decoction and artificial preparation of herbal and related products thereof | 中国医学科学院基础医学研究所 | 2023-09-15 | — | — | CN | disclosed |
| CN-111971072-B | Extraction of plant-derived decoction and artificial preparation of herbal and related products thereof | 中国医学科学院基础医学研究所 | 2023-06-13 | — | — | CN | disclosed |
| US-20210113641-A1 | EXTRACTION OF PLANT SOURCE \"MEDICINAL SOUP\" AND MANUAL PREPARATION OF \"HERBAL MEDICINE\" AND RELATED PRODUCTS | BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) CO., LTD (CN) | 2021-04-22 | — | — | US | disclosed |
| US-20210108198-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT AND RELATED PRODUCTS THEREOF | BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) CO., LTD (CN) | 2021-04-15 | — | — | US | disclosed |
| US-20210100905-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS | BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) CO., LTD (CN) | 2021-04-08 | — | — | US | disclosed |
| EP-3789043-A1 | EXTRACTION OF PLANT SOURCE \"MEDICINAL SOUP\" AND MANUAL PREPARATION OF \"HERBAL MEDICINE\" AND RELATED PRODUCTS | Institute of Basic Medical Sciences, Chinese Academi of Medical Sciences (CN) | 2021-03-10 | — | — | EP | disclosed |
| EP-3778556-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS | Institute of Basic Medical Sciences, Chinese Academi of Medical Sciences (CN) | 2021-02-17 | — | — | EP | disclosed |
| EP-3604269-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT AND RELATED PRODUCTS THEREOF | Institute of Basic Medical Sciences, Chinese Academi of Medical Sciences (CN) | 2020-02-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260000768-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS | FABP2, NSUN2, TRDMT1 | SELP 3100/4885FABP3 5/4885LPAR3 302/4885 |
| US-20250345290-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT AND RELATED PRODUCTS THEREOF | TRDMT1, HNRNPAB, HNRNPA1 | SELP 3659/4885FABP3 673/4885LPAR3 1325/4885 |
| US-12280114-B2 | Extraction of plant source “medicinal soup” and manual preparation of “herbal medicine” and related products | CHMP4B, FIP1L1, LIPC | SELP 1122/4885FABP3 2236/4885LPAR3 3588/4885 |
| US-20250041423-A1 | EXTRACTION OF PLANT SOURCE \"MEDICINAL SOUP\" AND MANUAL PREPARATION OF \"HERBAL MEDICINE\" AND RELATED PRODUCTS | CHMP4B, EXOSC5, FIP1L1 | SELP 600/4885FABP3 1435/4885LPAR3 3469/4885 |
| US-20210100905-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS | TRDMT1, SNRPE, HNRNPAB | SELP 3490/4885FABP3 648/4885LPAR3 1068/4885 |
| US-20210113641-A1 | EXTRACTION OF PLANT SOURCE \"MEDICINAL SOUP\" AND MANUAL PREPARATION OF \"HERBAL MEDICINE\" AND RELATED PRODUCTS | CHMP4B, EXOSC5, FIP1L1 | SELP 600/4885FABP3 1435/4885LPAR3 3469/4885 |
| US-20210108198-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT AND RELATED PRODUCTS THEREOF | TRDMT1, HNRNPAB, HNRNPA1 | SELP 3659/4885FABP3 673/4885LPAR3 1325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.